Sharon Barr
- Molecular Biology top 5%
- Genetics top 0.5%
- Surgery top 2%
- Oncology top 5%
- Biomaterials top 2%
- Co-authors
- Stephen E. EpsteinEugenio StabileMary Susan BurnettSabine FuchsTimothy KinnairdMagang ShouTim KinnairdShmuel Fuchs
- Topics
- PI3K/AKT/mTOR signaling in cancer (11 papers)Lung Cancer Treatments and Mutations (5 papers)Fungal Plant Pathogen Control (2 papers)
- Cited by
- GeneticsBiomaterialsCancer Research
- Partner nations
- United StatesFranceSpain
In The Last Decade
Sharon Barr
27 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Molecular Biology 1.9k
- Genetics 1.6k
- Surgery 1.2k
- Oncology 646
- Biomaterials 566
Countries citing papers authored by Sharon Barr
This map shows the geographic impact of Sharon Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Barr more than expected).
Fields of papers citing papers by Sharon Barr
This network shows the impact of papers produced by Sharon Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Barr. The network helps show where Sharon Barr may publish in the future.
Co-authorship network of co-authors of Sharon Barr
This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Barr. A scholar is included among the top collaborators of Sharon Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Barr. Sharon Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 48 | |
| 2 | 67 | |
| 3 | 1 | |
| 4 | 38 | |
| 5 | 80 | |
| 6 | 85 | |
| 7 | 1 | |
| 8 | 145 | |
| 9 | 6 | |
| 10 | 164 | |
| 11 | 169 | |
| 12 | The EGFR antagonist, erlotinib, combined with a small molecule inhibitor of IGF-1R acts synergistically to inhibit proliferation and induce apoptosis in ovarian and HNSCC cells | 3 |
| 13 | Inhibition of IGF-1R by OSI-906 potentiates efficacy of various molecular targeted agents by blocking feedback loops converging at the level of IRS-1 | 1 |
| 14 | Differential effects for small molecule versus antibody inhibitors of EGFR: Erlotinib, but not the neutralizing antibody C225, achieves inhibition of the EGFR-HER3-Akt signaling cascade | 1 |
| 15 | 24 | |
| 16 | Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanismsbreakdown → | 1121 |
| 17 | Local Delivery of Marrow-Derived Stromal Cells Augments Collateral Perfusion Through Paracrine Mechanismsbreakdown → | 1059 |
| 18 | 83 | |
| 19 | 48 | |
| 20 | 103 |
About Sharon Barr
Sharon Barr is a scholar working on Genetics, Cancer Research and Molecular Biology, having authored 27 papers that have together received 3.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (11 papers), Lung Cancer Treatments and Mutations (5 papers) and Fungal Plant Pathogen Control (2 papers). The work is most often cited by research in Genetics (1.6k citations), Biomaterials (566 citations) and Cancer Research (484 citations). Sharon Barr has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Stephen E. Epstein, Eugenio Stabile, Mary Susan Burnett, Sabine Fuchs, Timothy Kinnaird, Magang Shou, Tim Kinnaird, Shmuel Fuchs, Edward M. Johnson and Elizabeth Buck. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.